A primer on strategies for prevention and control of seasonal and pandemic influenza.
Identifieur interne : 001691 ( PubMed/Checkpoint ); précédent : 001690; suivant : 001692A primer on strategies for prevention and control of seasonal and pandemic influenza.
Auteurs : Scott Santiba Ez [États-Unis] ; Anthony E. Fiore ; Toby L. Merlin ; Stephen ReddSource :
- American journal of public health [ 1541-0048 ] ; 2009.
Descripteurs français
- KwdFr :
- Accessibilité des services de santé, Antiviraux (usage thérapeutique), Department of Health and Human Services (USA), Flambées de maladies (), Grippe humaine (), Grippe humaine (traitement médicamenteux), Grippe humaine (épidémiologie), Humains, Politique de santé, Populations vulnérables, Quarantaine, Sous-type H1N1 du virus de la grippe A, Vaccins antigrippaux (usage thérapeutique), États-Unis d'Amérique.
- MESH :
- traitement médicamenteux : Grippe humaine.
- usage thérapeutique : Antiviraux, Vaccins antigrippaux.
- épidémiologie : Grippe humaine.
- Accessibilité des services de santé, Department of Health and Human Services (USA), Flambées de maladies, Grippe humaine, Humains, Politique de santé, Populations vulnérables, Quarantaine, Sous-type H1N1 du virus de la grippe A, États-Unis d'Amérique.
- Wicri :
- geographic : États-Unis.
English descriptors
- KwdEn :
- Antiviral Agents (therapeutic use), Disease Outbreaks (prevention & control), Health Policy, Health Services Accessibility, Humans, Influenza A Virus, H1N1 Subtype, Influenza Vaccines (therapeutic use), Influenza, Human (drug therapy), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Quarantine, United States, United States Dept. of Health and Human Services, Vulnerable Populations.
- MESH :
- chemical , therapeutic use : Antiviral Agents, Influenza Vaccines.
- geographic : United States.
- drug therapy : Influenza, Human.
- epidemiology : Influenza, Human.
- prevention & control : Disease Outbreaks, Influenza, Human.
- Health Policy, Health Services Accessibility, Humans, Influenza A Virus, H1N1 Subtype, Quarantine, United States Dept. of Health and Human Services, Vulnerable Populations.
Abstract
The United States has made considerable progress in pandemic preparedness. Limited attention, however, has been given to the challenges faced by populations that will be at increased risk of the consequences of the pandemic, including challenges caused by societal, economic, and health-related factors. This supplement to the American Journal of Public Health focuses on the challenges faced by at-risk and vulnerable populations in preparing for and responding to an influenza pandemic. Here, we provide background information for subsequent articles throughout the supplement. We summarize (1) seasonal influenza epidemiology, transmission, clinical illness, diagnosis, vaccines, and antiviral medications; (2) H5N1 avian influenza; and (3) pandemic influenza vaccines, antiviral medications, and nonpharmaceutical interventions.
DOI: 10.2105/AJPH.2009.164848
PubMed: 19797735
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:19797735Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A primer on strategies for prevention and control of seasonal and pandemic influenza.</title><author><name sortKey="Santiba Ez, Scott" sort="Santiba Ez, Scott" uniqKey="Santiba Ez S" first="Scott" last="Santiba Ez">Scott Santiba Ez</name><affiliation wicri:level="1"><nlm:affiliation>Centers for Disease Control and Prevention, 1600 Clifton Rd, MS A-20, Atlanta GA 30333, USA. ssantibanez@cdc.gov</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Centers for Disease Control and Prevention, 1600 Clifton Rd, MS A-20, Atlanta GA 30333</wicri:regionArea><wicri:noRegion>Atlanta GA 30333</wicri:noRegion></affiliation></author><author><name sortKey="Fiore, Anthony E" sort="Fiore, Anthony E" uniqKey="Fiore A" first="Anthony E" last="Fiore">Anthony E. Fiore</name></author><author><name sortKey="Merlin, Toby L" sort="Merlin, Toby L" uniqKey="Merlin T" first="Toby L" last="Merlin">Toby L. Merlin</name></author><author><name sortKey="Redd, Stephen" sort="Redd, Stephen" uniqKey="Redd S" first="Stephen" last="Redd">Stephen Redd</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2009">2009</date><idno type="RBID">pubmed:19797735</idno><idno type="pmid">19797735</idno><idno type="doi">10.2105/AJPH.2009.164848</idno><idno type="wicri:Area/PubMed/Corpus">001617</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001617</idno><idno type="wicri:Area/PubMed/Curation">001617</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001617</idno><idno type="wicri:Area/PubMed/Checkpoint">001691</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001691</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">A primer on strategies for prevention and control of seasonal and pandemic influenza.</title><author><name sortKey="Santiba Ez, Scott" sort="Santiba Ez, Scott" uniqKey="Santiba Ez S" first="Scott" last="Santiba Ez">Scott Santiba Ez</name><affiliation wicri:level="1"><nlm:affiliation>Centers for Disease Control and Prevention, 1600 Clifton Rd, MS A-20, Atlanta GA 30333, USA. ssantibanez@cdc.gov</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Centers for Disease Control and Prevention, 1600 Clifton Rd, MS A-20, Atlanta GA 30333</wicri:regionArea><wicri:noRegion>Atlanta GA 30333</wicri:noRegion></affiliation></author><author><name sortKey="Fiore, Anthony E" sort="Fiore, Anthony E" uniqKey="Fiore A" first="Anthony E" last="Fiore">Anthony E. Fiore</name></author><author><name sortKey="Merlin, Toby L" sort="Merlin, Toby L" uniqKey="Merlin T" first="Toby L" last="Merlin">Toby L. Merlin</name></author><author><name sortKey="Redd, Stephen" sort="Redd, Stephen" uniqKey="Redd S" first="Stephen" last="Redd">Stephen Redd</name></author></analytic><series><title level="j">American journal of public health</title><idno type="eISSN">1541-0048</idno><imprint><date when="2009" type="published">2009</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral Agents (therapeutic use)</term><term>Disease Outbreaks (prevention & control)</term><term>Health Policy</term><term>Health Services Accessibility</term><term>Humans</term><term>Influenza A Virus, H1N1 Subtype</term><term>Influenza Vaccines (therapeutic use)</term><term>Influenza, Human (drug therapy)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (prevention & control)</term><term>Quarantine</term><term>United States</term><term>United States Dept. of Health and Human Services</term><term>Vulnerable Populations</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Accessibilité des services de santé</term><term>Antiviraux (usage thérapeutique)</term><term>Department of Health and Human Services (USA)</term><term>Flambées de maladies ()</term><term>Grippe humaine ()</term><term>Grippe humaine (traitement médicamenteux)</term><term>Grippe humaine (épidémiologie)</term><term>Humains</term><term>Politique de santé</term><term>Populations vulnérables</term><term>Quarantaine</term><term>Sous-type H1N1 du virus de la grippe A</term><term>Vaccins antigrippaux (usage thérapeutique)</term><term>États-Unis d'Amérique</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>United States</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Disease Outbreaks</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Health Policy</term><term>Health Services Accessibility</term><term>Humans</term><term>Influenza A Virus, H1N1 Subtype</term><term>Quarantine</term><term>United States Dept. of Health and Human Services</term><term>Vulnerable Populations</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Accessibilité des services de santé</term><term>Department of Health and Human Services (USA)</term><term>Flambées de maladies</term><term>Grippe humaine</term><term>Humains</term><term>Politique de santé</term><term>Populations vulnérables</term><term>Quarantaine</term><term>Sous-type H1N1 du virus de la grippe A</term><term>États-Unis d'Amérique</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>États-Unis</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The United States has made considerable progress in pandemic preparedness. Limited attention, however, has been given to the challenges faced by populations that will be at increased risk of the consequences of the pandemic, including challenges caused by societal, economic, and health-related factors. This supplement to the American Journal of Public Health focuses on the challenges faced by at-risk and vulnerable populations in preparing for and responding to an influenza pandemic. Here, we provide background information for subsequent articles throughout the supplement. We summarize (1) seasonal influenza epidemiology, transmission, clinical illness, diagnosis, vaccines, and antiviral medications; (2) H5N1 avian influenza; and (3) pandemic influenza vaccines, antiviral medications, and nonpharmaceutical interventions.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19797735</PMID><DateCompleted><Year>2009</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1541-0048</ISSN><JournalIssue CitedMedium="Internet"><Volume>99 Suppl 2</Volume><PubDate><Year>2009</Year><Month>Oct</Month></PubDate></JournalIssue><Title>American journal of public health</Title><ISOAbbreviation>Am J Public Health</ISOAbbreviation></Journal><ArticleTitle>A primer on strategies for prevention and control of seasonal and pandemic influenza.</ArticleTitle><Pagination><MedlinePgn>S216-24</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2105/AJPH.2009.164848</ELocationID><Abstract><AbstractText>The United States has made considerable progress in pandemic preparedness. Limited attention, however, has been given to the challenges faced by populations that will be at increased risk of the consequences of the pandemic, including challenges caused by societal, economic, and health-related factors. This supplement to the American Journal of Public Health focuses on the challenges faced by at-risk and vulnerable populations in preparing for and responding to an influenza pandemic. Here, we provide background information for subsequent articles throughout the supplement. We summarize (1) seasonal influenza epidemiology, transmission, clinical illness, diagnosis, vaccines, and antiviral medications; (2) H5N1 avian influenza; and (3) pandemic influenza vaccines, antiviral medications, and nonpharmaceutical interventions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Santibañez</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, 1600 Clifton Rd, MS A-20, Atlanta GA 30333, USA. ssantibanez@cdc.gov</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fiore</LastName><ForeName>Anthony E</ForeName><Initials>AE</Initials></Author><Author ValidYN="Y"><LastName>Merlin</LastName><ForeName>Toby L</ForeName><Initials>TL</Initials></Author><Author ValidYN="Y"><LastName>Redd</LastName><ForeName>Stephen</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Public Health</MedlineTA><NlmUniqueID>1254074</NlmUniqueID><ISSNLinking>0090-0036</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006291" MajorTopicYN="N">Health Policy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006297" MajorTopicYN="N">Health Services Accessibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053118" MajorTopicYN="Y">Influenza A Virus, H1N1 Subtype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011790" MajorTopicYN="N">Quarantine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014483" MajorTopicYN="N">United States Dept. of Health and Human Services</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035862" MajorTopicYN="N">Vulnerable Populations</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>10</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19797735</ArticleId><ArticleId IdType="pii">99/S2/S216</ArticleId><ArticleId IdType="doi">10.2105/AJPH.2009.164848</ArticleId><ArticleId IdType="pmc">PMC4504386</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Infect Dis. 1999 Aug;180(2):254-61</Citation><ArticleIdList><ArticleId IdType="pubmed">10395837</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2006;11(5):122-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16757853</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2007 Aug 8;298(6):644-54</Citation><ArticleIdList><ArticleId IdType="pubmed">17684187</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2006 Dec;12(12):1841-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17326934</ArticleId></ArticleIdList></Reference><Reference><Citation>Biosecur Bioterror. 2006;4(4):366-75</Citation><ArticleIdList><ArticleId IdType="pubmed">17238820</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Suppl. 2006 Apr 28;55(1):3-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16645574</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Top Microbiol Immunol. 2006;304:131-52</Citation><ArticleIdList><ArticleId IdType="pubmed">16989268</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2008 Sep 26;57(38):1039-43</Citation><ArticleIdList><ArticleId IdType="pubmed">18818583</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2007 Aug 18;370(9587):580-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17707753</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1997 Sep 25;337(13):874-80</Citation><ArticleIdList><ArticleId IdType="pubmed">9302301</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2008 Apr 26;371(9622):1427-34</Citation><ArticleIdList><ArticleId IdType="pubmed">18400288</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2008 Nov 25;26(50):6383-91</Citation><ArticleIdList><ArticleId IdType="pubmed">18801398</ArticleId></ArticleIdList></Reference><Reference><Citation>Obstet Gynecol. 2004 Nov;104(5 Pt 1):1125-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15516422</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2008 Oct;8(10):650-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18922487</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1995 Nov;172(5):1352-5</Citation><ArticleIdList><ArticleId IdType="pubmed">7594676</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2007 Apr;7(4):257-65</Citation><ArticleIdList><ArticleId IdType="pubmed">17376383</ArticleId></ArticleIdList></Reference><Reference><Citation>Antivir Ther. 2007;12(4):501-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17668558</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Respir Infect. 1992 Mar;7(1):26-37</Citation><ArticleIdList><ArticleId IdType="pubmed">1609165</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1998 Feb 14;351(9101):467-71</Citation><ArticleIdList><ArticleId IdType="pubmed">9482437</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2007 Dec 15;45(12):1568-75</Citation><ArticleIdList><ArticleId IdType="pubmed">18190317</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2006 Jan;24(1):5-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16413916</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2004 Sep 15;292(11):1333-40</Citation><ArticleIdList><ArticleId IdType="pubmed">15367555</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1981 Nov;144(5):433-41</Citation><ArticleIdList><ArticleId IdType="pubmed">6273473</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 1980 Jan;111(1):13-22</Citation><ArticleIdList><ArticleId IdType="pubmed">7352453</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2008 Sep 1;198(5):642-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18576945</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Recomm Rep. 2008 Aug 8;57(RR-7):1-60</Citation><ArticleIdList><ArticleId IdType="pubmed">18685555</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2002 Mar 1;34(5):E23-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11807683</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2000 Nov 2;343(18):1282-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11058672</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2006 Nov 23;355(21):2186-94</Citation><ArticleIdList><ArticleId IdType="pubmed">17124016</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2008 Sep 1;198(5):629-31</Citation><ArticleIdList><ArticleId IdType="pubmed">18694337</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 1998 Feb 1;101(3):643-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9449698</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Public Health. 2009 Oct;99 Suppl 2:S243-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19797737</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2002 May 1;34 Suppl 2:S58-64</Citation><ArticleIdList><ArticleId IdType="pubmed">11938498</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4639-44</Citation><ArticleIdList><ArticleId IdType="pubmed">18332436</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 1998 Jun;26(6):1418-24</Citation><ArticleIdList><ArticleId IdType="pubmed">9636873</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1978 Mar 16;298(11):587-92</Citation><ArticleIdList><ArticleId IdType="pubmed">628375</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 2008 Apr 1;167(7):775-85</Citation><ArticleIdList><ArticleId IdType="pubmed">18230677</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2006 Nov 23;355(21):2179-85</Citation><ArticleIdList><ArticleId IdType="pubmed">17124015</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Prev Med. 2001 Aug;21(2):79-83</Citation><ArticleIdList><ArticleId IdType="pubmed">11457626</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Recomm Rep. 2009 Jul 31;58(RR-8):1-52</Citation><ArticleIdList><ArticleId IdType="pubmed">19644442</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Infect Dis J. 2008 Dec;27(12):1052-6</Citation><ArticleIdList><ArticleId IdType="pubmed">18978514</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 1975 Dec;102(6):553-63</Citation><ArticleIdList><ArticleId IdType="pubmed">1202957</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Public Health. 2009 Oct;99 Suppl 2:S248-54</Citation><ArticleIdList><ArticleId IdType="pubmed">19461110</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2008 Mar 1;197(5):667-75</Citation><ArticleIdList><ArticleId IdType="pubmed">18260764</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2006 Jan;12(1):88-94</Citation><ArticleIdList><ArticleId IdType="pubmed">16494723</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Infect Dis J. 2006 May;25(5):395-400</Citation><ArticleIdList><ArticleId IdType="pubmed">16645501</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2006 May 20;367(9523):1657-64</Citation><ArticleIdList><ArticleId IdType="pubmed">16714186</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Control Hosp Epidemiol. 2007 Sep;28(9):1071-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17932829</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2008 Jan 17;358(3):261-73</Citation><ArticleIdList><ArticleId IdType="pubmed">18199865</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Ther. 2007 Aug;29(8):1579-90; discussion 1577-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17919541</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics. 2004 Jun;113(6):1758-64</Citation><ArticleIdList><ArticleId IdType="pubmed">15173503</ArticleId></ArticleIdList></Reference><Reference><Citation>Paediatr Respir Rev. 2003 Jun;4(2):105-11</Citation><ArticleIdList><ArticleId IdType="pubmed">12758047</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2003 Oct 15;37(8):1094-101</Citation><ArticleIdList><ArticleId IdType="pubmed">14523774</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2007 Oct 17;(4):CD006207</Citation><ArticleIdList><ArticleId IdType="pubmed">17943895</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics. 1975 May;55(5):673-7</Citation><ArticleIdList><ArticleId IdType="pubmed">1168894</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2001 Feb 14;285(6):748-54</Citation><ArticleIdList><ArticleId IdType="pubmed">11176912</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Virol. 2001 Mar;63(3):242-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11170064</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2003 Jan 8;289(2):179-86</Citation><ArticleIdList><ArticleId IdType="pubmed">12517228</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoepidemiol Drug Saf. 2005 Aug;14(8):531-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15654722</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Infect Dis J. 2003 Feb;22(2):164-77</Citation><ArticleIdList><ArticleId IdType="pubmed">12586981</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2009 Apr 15;48(8):1003-32</Citation><ArticleIdList><ArticleId IdType="pubmed">19281331</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1999 Oct 9;354(9186):1277-82</Citation><ArticleIdList><ArticleId IdType="pubmed">10520648</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2006 Mar 30;354(13):1343-51</Citation><ArticleIdList><ArticleId IdType="pubmed">16571878</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2005 Jul 16-22;366(9481):225-33</Citation><ArticleIdList><ArticleId IdType="pubmed">16023513</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country></list><tree><noCountry><name sortKey="Fiore, Anthony E" sort="Fiore, Anthony E" uniqKey="Fiore A" first="Anthony E" last="Fiore">Anthony E. Fiore</name><name sortKey="Merlin, Toby L" sort="Merlin, Toby L" uniqKey="Merlin T" first="Toby L" last="Merlin">Toby L. Merlin</name><name sortKey="Redd, Stephen" sort="Redd, Stephen" uniqKey="Redd S" first="Stephen" last="Redd">Stephen Redd</name></noCountry><country name="États-Unis"><noRegion><name sortKey="Santiba Ez, Scott" sort="Santiba Ez, Scott" uniqKey="Santiba Ez S" first="Scott" last="Santiba Ez">Scott Santiba Ez</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001691 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001691 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:19797735
|texte= A primer on strategies for prevention and control of seasonal and pandemic influenza.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:19797735" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a PandemieGrippaleV1
| This area was generated with Dilib version V0.6.34. |  |